OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Profiling the metabolic disorder and detection of colorectal cancer based on targeted amino acids metabolomics
Yang Yang, Zhipeng Wang, Xinxing Li, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Yang Yang, Zhipeng Wang, Xinxing Li, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
Fusobacterium species are distinctly associated with patients with Lynch syndrome colorectal cancer
Felix Salim, Sayaka Mizutani, Satoshi Shiba, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110181-110181
Open Access | Times Cited: 5
Felix Salim, Sayaka Mizutani, Satoshi Shiba, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110181-110181
Open Access | Times Cited: 5
Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer
Zuojian Hu, Fenglin Shen, Liu Yang, et al.
Molecular Oncology (2025)
Open Access
Zuojian Hu, Fenglin Shen, Liu Yang, et al.
Molecular Oncology (2025)
Open Access
Exploring the Occurrence Mechanism and Early-Warning Model of Phlebitis Induced by Aescinate Based on Metabolomics in Cerebral Infarction Patients
Zhipeng Wang, You Yin, Yuhui Mu, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 343-355
Open Access | Times Cited: 2
Zhipeng Wang, You Yin, Yuhui Mu, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 343-355
Open Access | Times Cited: 2
LC–MS metabolomics analysis of serum metabolites during neoadjuvant chemoradiotherapy in locally advanced rectal cancer
Qiliang Peng, Lili Jiang, Yi Shen, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 1
Qiliang Peng, Lili Jiang, Yi Shen, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 1
GC-MS and Multivariate Analysis Reveal Partial Serum Metabolome Restoration by Bevacizumab in a Colon Cancer Rat Model: An untargeted metabolomics investigation
Maram H. Abduljabbar, Yusuf S. Althobaiti, Reem M. Alnemari, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 253, pp. 116562-116562
Closed Access
Maram H. Abduljabbar, Yusuf S. Althobaiti, Reem M. Alnemari, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 253, pp. 116562-116562
Closed Access
Synthesis of Ti4+ modified COF-based polymer for efficient enrichment of phosphopeptides in colorectal cancer serum
Bengui Jiang, Yannan Cai, Zhenzhen Cao, et al.
Microchemical Journal (2024) Vol. 207, pp. 112183-112183
Closed Access
Bengui Jiang, Yannan Cai, Zhenzhen Cao, et al.
Microchemical Journal (2024) Vol. 207, pp. 112183-112183
Closed Access
A Phase 1b study of the OxPhos inhibitor ME-344 with bevacizumab in refractory metastatic colorectal cancer
Patrick M. Boland, Heinz‐Josef Lenz, Kristen K. Ciombor, et al.
Investigational New Drugs (2024)
Open Access
Patrick M. Boland, Heinz‐Josef Lenz, Kristen K. Ciombor, et al.
Investigational New Drugs (2024)
Open Access
